|
HS Code |
518300 |
| Product Name | 6-Bromoindole-2-Carboxylic Acid |
| Cas Number | 1454-97-3 |
| Molecular Formula | C9H6BrNO2 |
| Molecular Weight | 240.06 |
| Appearance | Off-white to yellow solid |
| Melting Point | 271-275°C |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water, soluble in DMSO and methanol |
| Storage Conditions | Store at room temperature, keep container tightly closed, protect from light |
| Iupac Name | 6-bromo-1H-indole-2-carboxylic acid |
| Smiles | C1=CC2=C(C(=C1)Br)NC(=C2)C(=O)O |
As an accredited 6-Bromoindole-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 6-Bromoindole-2-Carboxylic Acid is packaged in a 5-gram amber glass vial, sealed and labeled with hazard information. |
| Shipping | 6-Bromoindole-2-Carboxylic Acid is shipped in secure, sealed packaging to ensure chemical integrity during transit. It is handled in compliance with hazardous material regulations, utilizing appropriate labeling and documentation. The shipment is temperature-controlled if necessary, with tracking provided to ensure safe and timely delivery to the recipient. |
| Storage | 6-Bromoindole-2-Carboxylic Acid should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from direct sunlight and moisture. It should be kept at room temperature and segregated from incompatible substances, such as strong oxidizers. Proper labeling and secure shelving are recommended to prevent accidental spills or contamination. |
Applications of 6-Bromoindole-2-Carboxylic Acid in Industrial Manufacturing6-Bromoindole-2-carboxylic acid serves as a specialized intermediate in several highly regulated downstream industries, particularly within pharmaceutical active ingredient synthesis, advanced agrochemical development, specialty dye production, and chemical research for fine organic synthesis. The following application scenarios outline its specific role, addressing industry standards, standardized incorporation rates, manufacturing process steps, and typical final product categories adopted by our major industrial clients. 1. Pharmaceutical Intermediates: Heterocyclic Drug SynthesisIn the pharmaceutical sector, this indole derivative forms a critical scaffold for synthesizing various heterocyclic drug candidates, particularly targeting anti-inflammatory, anticancer, and central nervous system compounds. Production facilities incorporate it primarily in the benzene ring functionalization stage, building proprietary molecules in compliance with stringent regulatory demands. Quality control documentation typically requires in-process verification for residual bromide and carboxylic moieties at each transformation step. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient DevelopmentComplex indole derivatives based on this raw material support the synthesis of new-generation crop protection agents, including fungicides and insecticides within structure–activity relationship optimization campaigns. Agrochemical formulators require precise specification matches and trace element control to meet residue and environmental thresholds when developing new actives for large-scale field deployment. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Organic Synthesis for Specialty Dye ManufacturingManufacturers utilize this compound as a functionalized indole precursor during the design of high-purity specialty dyes and fluorescent markers. Its bromine and carboxylic acid groups enable the synthesis of conjugated aromatic systems with unique photophysical properties, informing commercial dye development for biotechnology, microelectronics, and analytical labeling applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Research: Scaffolding for Fine Organic SynthesisLeading chemical and academic laboratories select this advanced indole acid as a building block for synthesizing novel heterocyclic structures, particularly for structure–activity relationship studies and lead molecule development. Control over functional group introduction at the bromine and carboxylic positions allows researchers to create customized, library-grade chemical entities for patented material discovery projects. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 6-Bromoindole-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 6-Bromoindole-2-Carboxylic Acid isn’t just a matter of adding reactants and watching the clock. Every batch comes from years of specialized process development and continual adjustments. In our experience, no two lots ever turn out exactly the same unless strict process controls are in place, especially with halogenated indole derivatives like this one. We focus every production campaign on purity, particle consistency, and batch verification, knowing that researchers and synthesis chemists rely on reproducibility for their own results.
6-Bromoindole-2-Carboxylic Acid, with its CAS number 41270-19-9, offers a unique bromine-substituted structure on the indole backbone. The molecule’s structure—bromine at the 6-position and a carboxylic acid at the 2-position—translates to distinct synthetic behaviors, solubility patterns, and reactivity compared to other indole carboxylic acids. There’s no room for error when working with such fine details at the molecular level. Any trace impurity can mean the difference between a successful pharmaceutical intermediate and a failed reaction down the pipeline.
Producing 6-Bromoindole-2-Carboxylic Acid at manufacturing scale presents a set of hurdles you only recognize after repeated cycles of process optimization and scale-up. We’ve seen that brominating indoles while controlling for overhalogenation or side-chain modifications needs finely tuned conditions—careful temperature management, precise reagent additions, and rapid post-reaction workup. In the beginning, small changes in the brominating agent’s addition rate gave differing impurity profiles, so we implemented inline analytical controls and batch segmentation. Today’s procedure reflects a thorough understanding of reagent behavior through hundreds of pilot and production runs.
Similar products may look alike on a certificate of analysis, but subtle factors set this compound apart. Bromine at the 6-position imparts electronic effects that alter the compound's nucleophilicity compared to the 5- or 7-position isomers. These differences affect downstream reactions, such as quick acylations or selective oxidations, and most researchers notice the change in yield or byproduct formation right away. From a manufacturing perspective, that means each isomer requires its own specialized production process and purification steps. We learned early on that a one-size-fits-all approach leads to lower yields or hard-to-remove byproducts, so we invested in separate equipment and changed solvent protocols to address these nuances.
Customers look for products that do exactly what they expect them to do. With 6-Bromoindole-2-Carboxylic Acid, pure white to off-white powder fits the visual bill, but consistency goes far beyond color or texture. We record GC-MS, HPLC, and NMR spectra for each lot, monitoring microcontaminants like residual iodine and related halogenated indole byproducts. More than once, minor fluctuations in retention times flagged shifts in side-product formation, so we draw on years of log data to inform real-time adjustments. Purity targets sit above 98%, but true quality comes from minimizing carryover from upstream reagents, and our staff tails purification procedures specifically for each campaign’s impurity fingerprint.
Moisture content and stability always demand close attention. Many indole carboxylic acids pick up atmospheric moisture and clump over time, which can complicate weight-out or handling in formulation labs. We use vacuum drying and nitrogen-purged storage—lessons learned from failed early shipments where slight hygroscopicity led to unusable product. These remedial steps now come standard, and shipments regularly include data logs from the drying and packaging process. That transparency reassures QC chemists on the receiving end—something we experienced firsthand after multiple feedback cycles with partner labs.
Most requests for 6-Bromoindole-2-Carboxylic Acid come from researchers improving synthetic routes for pharmaceuticals, agrochemicals, and fine chemicals. Bromine at the 6-position gives chemists a powerful lever to direct cross-coupling and palladium-catalyzed reactions, especially where position-specific substitution matters for biological activity. Novel kinase inhibitors, antifungal agents, and substituted tryptamines trace development roots to 6-bromoindole scaffolds. Requests for larger lots often come when lead compounds move into scale-up trials after successful early-stage syntheses in academic or industrial labs.
We talk with end users frequently—as much about their needs as about our own process. Some ask for more than just 10-gram bottles; kilo lots intended for active ingredient synthesis must meet GMP-like requirements. That means documentation backs up every purity figure and trace metal analysis, since unknowns can disrupt pilot plant operations. Recently, process chemists from multiple pharmaceutical partners asked for insight on controlling byproducts during Suzuki reactions involving 6-Bromoindole-2-Carboxylic Acid. Our support team dug into historical process records, providing test results from alternative crystallization methods and recommendations on solvent/temperature controls. For many customers, this manufacturer-level knowledge closes gaps that stockroom resellers can’t fill—once you know the path from raw starting material to finished compound, troubleshooting bottlenecks in the customer’s lab gets easier.
It’s not just about maximizing output per batch; it’s about making sure each gram delivers the result your chemistry depends on. That mindset guides our decisions on everything from solvent recovery to how often we switch out glassware between campaigns. Small losses during filtration or transfer matter less than known consistency and absence of contamination. It’s a mentality born from seeing the outcome of a single contaminated intermediate—a failed clinical candidate that set back timelines by months.
Bromination on the indole ring is rarely simple. 5-, 6-, and 7-bromo isomers react differently under identical conditions. We learned this after developing each isomer’s specific production route for clients who required one over the others. 6-Bromoindole-2-Carboxylic Acid, for example, generally shows higher reactivity in palladium-catalyzed couplings at the bromo site compared to its 5-bromo counterpart. This difference owes to the electronic influences around the ring: the 6-position is more reactive toward oxidative addition, which helps chemists select which intermediate performs best for their needs.
This isomeric difference also shows up in physical handling. 5-Bromoindole-2-Carboxylic Acid tends to form more compact, harder-to-dissolve powders, while the 6-bromo form handles readily and dissolves faster in organic solvents like DMF and DMSO. For labs working on rapid throughput or automated processes, this behavior makes a difference in day-to-day work. We switched packaging protocols for the 6-bromo product to account for a more flowable powder, avoiding static clinging or bridging issues common in automated dispensing.
As with every variant, unique process modifications often follow from real-world demands. For instance, one of our long-term partners wanted a photostable variant for a light-sensitive coupling reaction. That prompted us to double down on protection from visible light during drying and storage—a step we might have overlooked without their insight. Such incremental improvements reflect a back-and-forth dialogue with users who push the compound into new territory year after year.
Scaling production for 6-Bromoindole-2-Carboxylic Acid brings its own set of realities. At 500-gram scale, slight temperature shifts or uneven mixing can magnify impurity patches, turning a simple lab method unreliable for even a modest pilot campaign. We’ve invested heavily in equipment that monitors mixing efficiency, jacket temperature, and real-time pH fluctuations. That allows us to catch deviations as they emerge, rather than reworking failed batches, which not only wastes material but can also clog schedules.
Every production run generates detailed electronic records, covering batch composition, reagent lots, and even ambient humidity during workup and drying. These records feed a central database, creating traceability across production cycles. Over years of use, the build-up of such data helped us tune reaction controls—detecting patterns missed by spot-checking alone. For instance, we refined our crystallization steps after seeing consistently higher impurity levels in summer versus winter runs, linking the trend back to higher temperatures and solvent vapor loss. Knowing this, we installed additional HVAC and vapor condensation lines, closing the gap in batch-to-batch variability.
Lab-developed syntheses tend to run hotter, faster, and with more concentrated reagents than large-scale batches. Early on, we tried duplicating small-scale methods at the pilot plant—which just led to scale-up headaches. Ellery reactors, overhead stirrers, and monitored reagent feeds have grown standard, ensuring kinetic and thermal stability as the scale grows. Having trained operators on hand who know the signs of foaming, aggregation, or undesired color changes—skills often overlooked by pure analytical QC—prevents problems from propagating through downstream purification.
Having regular conversations with researchers, medicinal chemists, and process engineers has shaped how we make and package 6-Bromoindole-2-Carboxylic Acid. Some need lots under inert gas with ultra-low metal specs, others want larger, non-standard quantities—each request teaches us something about new applications or formulation constraints. A medicinal chemistry group wanted non-standard particle size distribution for their automated screening platform, which required us to invest in scalable sieving and milling capabilities. The learning curve on such requests rarely comes from textbooks; instead, it’s the feedback from handling, processing, and analytical results over dozens of shipments and months of follow-up.
Unexpected use-cases continue to surface. Researchers developing fluorescent probes found new interactions for indole-bromo compounds in bio-imaging, which meant we adapted purification sulfates to remove potential quenchers. Agricultural scientists reached out for advice on synthesizing new growth regulators from the 6-bromo carboxylic acid backbone; their input led us to explore solvent recycling strategies compatible with plant-borne actives. Each request, whether for classic cross-couplings or new discovery science, shapes ongoing tweaks to the process—sometimes small, sometimes transformative.
Direct communication builds trust on both sides. We learned early that end users place as much value on real-time technical support as on certificates of analysis. When shipment delays happen, we’re transparent. When unexpected results show up in user labs, we review our batch histories for clues. Building that relationship, sharing technical details, and staying open to collaboration assures labs of a manufacturer’s commitment far beyond what static product listings can express.
No industrial process runs perfectly on its own. The chemistry of 6-Bromoindole-2-Carboxylic Acid occasionally generates off-color residues or tough-to-remove halogenated byproducts. Years of operator feedback and analytical review led us to install multi-stage filtration and chromatographic separation units. Occasionally, an impurity slips through—when it happens, every affected batch is traced and corrected using historical impurity data, sometimes pending customer application feedback on batch suitability. This continual drive for analytical verification, not mere procedural adherence, separates manufacturing from simple “make-and-ship” operations.
Solubility can waver depending on lot and storage age; unadapted drying or incorrect solvent choice causes product clumping or reduced performance in downstream reactions. We trialed multiple anti-caking agents only to find they contributed traces of unexpected elements, so we reverted to tightly controlled drying, sieving, and nitrogen storage. Protecting the carboxylic acid from hydrolysis or photodegradation led to double-layered, UV-resistant containers and temperature loggers in every shipment.
We often collaborate with logistics partners to ensure cold-chain or light-protected delivery. A missed shipment window on a hot day used to mean lost batches—costly and preventable. Now, with improved forecasting and shipping notification, even bulk orders move safely to customer sites worldwide.
The scale of halogenated organic manufacture demands attention to environmental impact. Years back, stricter discharge requirements for bromine waste forced us to rethink waste stream handling. Now, bromide-rich byproducts are captured, neutralized, and reclaimed where possible, reducing total waste disposal. Each process revision halves chemical waste per batch, demonstrating that profit and responsibility don't always stand at odds. Beyond regulatory compliance, this mindfully reduces our environmental footprint—a lesson learned over time, not from a rulebook.
Increasing solvent recovery cut production costs and reduced flammable waste stored onsite. Our process now reuses over half the DMF, DMSO, and acetonitrile required in main-stage reactions. In every campaign, operators document solvent throughput, recycling rates, and emissions, building peer-reviewed evidence of progress. Suppliers, recognizing our demands, have raised their own compliance practices, providing us with raw materials that meet higher internal standards for trace metals and residual solvents.
Manufacturing 6-Bromoindole-2-Carboxylic Acid is a craft shaped by years of incremental improvement, partnership, and technical problem-solving. The compound’s popularity in pharmaceutical and agricultural research continues to grow, and demands for custom modifications, tighter purities, and greener production will shape our methods going forward. Investment in new process equipment, more sophisticated trace analysis, and continuous operator training show up in every batch shipped. These steps take time and resources, but every technical challenge solved by the manufacturer keeps downstream innovation moving—whether toward new medications, crop protections, or foundational chemical science.
Each bottle, drum, or kilogram of 6-Bromoindole-2-Carboxylic Acid carries with it more than a list of analytical values; it represents a hands-on record of improvement, user feedback, technical troubleshooting, and collaboration. This ongoing process is what lets manufacturers deliver on specifications, timelines, and the implicit promise that each shipment will keep pushing research and industry forward in ways few other links in the chemical supply chain can match.